Followers | 221 |
Posts | 13853 |
Boards Moderated | 0 |
Alias Born | 08/12/2011 |
Wednesday, February 06, 2019 11:56:51 AM
The real question that we need to ask ourselves is not who is still with the company, who has left, who is leaving, and who is coming. That is what Fantasyland wants one to believe.
The real focus should be on these...
Do we still have 9-family of patents and over 30 patents waiting to be granted?
Did we have some clinical done at reputable and respected research hospitals?
Do we still have more clinical going on at those places?
Is company doing these on a penny on a dollar budget?
Does company have enough money to pay for these penny-on-dollar expenses?
Does company have the IP protected?
If the answer to all the above is yes, then it is only a matter of time this company become a multi-dollar stock company knowing that company cannot control the timeline/schedule of the studies at Sheba much. (Sheba is doing the clinicals for several other Bio-Pharma companies).
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM